EXECUTIVE COMMITTEE

 
 

Kenneth C. Frazier

Kenneth C. Frazier
Chairman of the Board and Chief Executive Officer

• Chairman of the board and chief executive officer, Merck & Co., Inc., 2011

• President, Merck & Co., Inc., 2010

• Executive vice president and president, Global Human Health, Merck & Co., Inc., 2007

• Executive vice president and general counsel, Merck & Co., Inc., 2006-2007

• Senior vice president and general counsel, Merck & Co., Inc., 1999-2006

Read bio

 
Sanat Chattopadhyay

Sanat Chattopadhyay
Executive Vice President and President, MSD Manufacturing Division

• Executive vice president and president, MSD Manufacturing Division, 2016

• Senior vice president, Operations, MSD Manufacturing Division, 2009-2016

• Senior vice president, New Products & Process Development, Wyeth Pharmaceuticals 2007-2009

• Vice president, Technical Operations & Product Supply, Wyeth Pharmaceuticals, 2005-2007

• Senior vice president, Product Development & Supply, Aventis Pharmaceuticals, 2003-2005

 
Robert M. Davis

Robert M. Davis
Executive Vice President, Chief Financial Officer and Global Services

• Executive vice president, chief financial officer and global services, Merck & Co., Inc., 2016

• Executive vice president and chief financial officer, Merck & Co., Inc., 2014-2016

• Corporate vice president and president, Baxter Medical Products, 2010-2014

• Corporate vice president and chief financial officer, Baxter Healthcare, 2006-2010; treasurer, Baxter Healthcare, 2004-2006; Director of Corporate Financial Planning, Eli Lilly and Company, 2002-2004; assistant treasurer and various financial positions, Eli Lilly and Company, 1990-2002

 
Richard R. DeLuca Jr.

Richard R. DeLuca Jr.
Executive Vice President and President, MSD Animal Health

• Executive vice president and president, MSD Animal Health, 2011

• Chief financial officer, Becton Dickinson Biosciences, 2010-2011

• President, Wyeth's Fort Dodge Animal Health division, 2007-2010

• Chief operating officer, Fort Dodge, 2006-2007; executive vice president and chief financial officer, 2002-2006

• Vice president, Finance, Wyeth Pharmaceuticals, 1998-2002

 
Jolie L. Gerberding

Jolie L. Gerberding, M.D., M.P.H.
Executive Vice President & Chief Patient Officer, Strategic Communications, Global Public Policy and Popolation Health

• Executive vice president & chief patient officer, Strategic Communications, Global Public Policy and Popolation Health, Merck & Co., Inc., 2016

• President, MSD Vaccines, 2010-2014

• Co-Chair, Board of Directors, Sanofi Pasteur MSD Joint Venture, 2010-present

• Director, Centers for Disease Control and Prevention (CDC), 2002-2009

• Director, Division of Healthcare Quality Promotion, CDC, 1998-2002

• Adjunct Associate Clinical Professor of Medicine in Infectious Disease, University of California, San Francisco, 2002-present

 
Mirian M. Graddick-Weir

Mirian M. Graddick-Weir
Executive Vice President, Human Resources

• Executive vice president, Human Resources, Merck & Co., Inc., 2008

• Senior vice president, Human Resources, Merck & Co., Inc., 2006-2007

• Executive vice president, Human Resources and Employee Communications, AT&T, 2004-2006

• Executive vice president, Human Resources, AT&T, 1999-2004

• Chief human resources officer, Consumer Services Company, AT&T, 1998-1999

 
Roger M. Perlmutter

Roger M. Perlmutter, M.D., Ph.D.
Executive Vice President and President, MSD Research Laboratories

• Executive vice president and president, MSD Research Laboratories, 2013

• Executive vice president and head of Research and Development, Amgen Inc., 2001-2012

• Executive vice president of Worldwide Basic Research and Preclinical Development, MSD Research Laboratories, 1998-2001; senior vice president, MSD Research Laboratories, 1997-1998

• Professor, Departments of Immunology, Biochemistry and Medicine, University of Washington, 1991-1997

 
Adam H. Schechter

Adam H. Schechter
Executive Vice President and President, Global Human Health

• Executive vice president and president, Global Human Health, Merck & Co., Inc., 2010

• President, Global Pharmaceuticals, 2007-2010 and Integration Officer, Merck & Co., Inc., 2009-2010

• President, U.S. Human Health, Merck & Co., Inc., 2006-2007

• Senior vice president and general manager, U.S. Osteoporosis, Respiratory and Neuroscience, Merck & Co., Inc., 2005-2006

 
Jennifer Zachary

Jennifer Zachary
Executive Vice President and General Counsel

• Executive vice president and general counsel, Merck & Co., Inc., 2018

• Partner, Covington & Burling LLP, 2013-2018; Associate, Covington & Burling LLP, 2011-2013;

• U.S. Food and Drug Administration, Associate Chief Counsel for Enforcement, 2005-2011

• U.S. Attorney’s Office for the District of Columbia, Civil Division, Special Assistant U.S. Attorney, 2009


CODE OF CONDUCT: OUR VALUES AND STANDARDS


Our code of conduct reflects our corporate values and guides our day-to-day decision making.


Learn more